How Long Does BPC-157 Take to Work?

10 min readWritten by Protocol Health Editorial TeamMedically reviewed by Richard Dentico, MDPublished Updated

How long does BPC-157 take to work? There is no trial-based answer. People who use it commonly report gut-related changes within one to two weeks and tendon, ligament or joint changes over several weeks, but those timelines come from user reports, not controlled human studies. A 2025 systematic review found 35 animal studies and a single small human study. BPC-157 is not FDA-approved, and whether it is appropriate at all is a decision for a physician who knows your history.

How Long Does BPC-157 Take to Work?
Here’s what we’ll cover

Key takeaways

  • No controlled human study has measured how long BPC-157 takes to work. A 2025 review found 35 animal studies and one small human study (Vasireddi et al., 2025).
  • It leaves the blood in under 30 minutes. Half-life was below 30 minutes in rats and dogs (He et al., 2022).
  • Timelines online are user reports. Gut changes in one to two weeks and tissue changes over weeks are anecdotal, not trial results (Mendias et al., 2026).
  • It is not FDA-approved. The FDA lists it among bulk substances that may present safety risks (FDA).

Introduction

How long does it take BPC-157 to start working?

How long it takes BPC-157 to start working is the first question most people ask, and there is no single timeline. BPC-157 is a synthetic peptide (a short chain of amino acids based on a protective compound found in the digestive tract) that has been studied for its potential role in tissue repair and recovery. If you're considering it, you probably want a realistic sense of the timeline, not hype.

The honest answer is that it depends on what you're targeting, how you're using it, and your own biology, and much of the human evidence is still early. At Protocol Health in Scarsdale, NY, BPC-157 is used only where it's clinically appropriate, under physician supervision, as part of a broader recovery plan.

Quick Answer

BPC-157: how long to work, in short?

In short, on how long BPC-157 takes to work, most people who use it don't experience an overnight change. Gut- and digestion-related goals are often where people report noticing something soonest, sometimes within the first one to two weeks, while musculoskeletal goals like tendon, ligament, or joint recovery tend to unfold more gradually over several weeks.

Because responses vary and rigorous human trials remain limited, any timeline should be treated as a general expectation rather than a guarantee. A physician can help you set realistic milestones and track whether it's genuinely helping. In short, any change from BPC-157 is usually gradual, with gut-related changes reported sooner than tendon or joint changes.

What It Is

What is BPC-157 and how is it thought to work?

BPC-157, short for body protection compound 157, is a synthetic 15-amino-acid peptide based on a sequence from a protective protein in gastric juice. It has been studied for decades, mostly in rats, for its possible role in protecting the gut lining and repairing muscle, tendon, ligament and bone. Our what is BPC-157 and pentadecapeptide arginate guides cover the compound itself.

In those preclinical studies, BPC-157 appears to increase growth hormone receptor expression in tendon fibroblasts (Chang et al., 2014) and to activate pathways involved in new blood vessel formation (Seiwerth et al., 2018), while lowering inflammatory signaling. That proposed mechanism is why people expect it to work over weeks rather than hours: tissue remodeling is slow regardless of what drives it.

None of this has been confirmed in controlled human trials. BPC-157 is not FDA-approved for any use, so every timeline below should be read as an expectation, not a promise.

Timeline by Goal

How long for BPC-157 to work, by goal?

How long for BPC-157 to work depends on what you're trying to support: users describe gut changes within one to two weeks and soft-tissue or joint changes over several weeks.

Gut and digestive support: BPC-157 was originally identified from a protective compound in gastric juice, and gut-related goals are where users most often describe earlier changes, typically within one to two weeks. These are anecdotal reports, not trial results.

Soft-tissue recovery (tendon, ligament, muscle): this is typically a slower process. Users commonly describe gradual change over several weeks. No controlled human study has measured this timeline.

Joint and general recovery: this often falls in a similar multi-week window and depends heavily on the severity of the underlying issue and everything else you're doing to support healing. The timeline follows the goal: gut changes are reported soonest, and tissue changes take weeks.

The Evidence

What does the research say about how long BPC-157 takes to work?

The research cannot yet answer how long BPC-157 takes to work in people, because almost all of it is in animals. A 2025 systematic review in the HSS Journal screened 544 articles on BPC-157 in orthopaedic sports medicine and included 36 studies: 35 preclinical and one clinical. In the animal models, BPC-157 improved functional, structural and biomechanical outcomes in muscle, tendon, ligament and bone injuries.

The only clinical study in that review was a retrospective look at patients with unexplained chronic knee pain who received BPC-157 injections into the joint. Seven of 12 reported relief lasting more than six months. That is a small, uncontrolled case series with no placebo group, so it cannot tell you when relief started or whether BPC-157 caused it. The review graded the overall evidence as level IV and level V, the lowest tiers.

Expectation also shapes the timeline people report. A 2026 narrative review in Sports Medicine on approved and unapproved peptides for musculoskeletal injuries noted that rigorous human safety data for unapproved peptides are scarce, and discussed the placebo effect, amplified by social media, as a mediator of reported benefit. When someone says BPC-157 worked in ten days, natural healing and expectation are part of that ten days.

What Affects the Timeline

Why two people can have very different experiences

Two people can have very different experiences with BPC-157 because several factors shape how quickly, if at all, someone responds: the type and severity of what you're addressing, the route and consistency of use, your age and overall health, and whether BPC-157 is paired with the right rehab, nutrition, sleep, and training.

It also matters whether the underlying problem is something a peptide can realistically influence. Part of a proper evaluation is deciding whether BPC-157 is even the right tool, or whether something else deserves attention first. Our best peptides for injury recovery and BPC-157 vs TB-500 guides compare the options.

What to Expect

A realistic arc, not a fixed schedule

BPC-157 follows a realistic arc, not a fixed schedule: early on, many people notice no clear change, and that is not evidence either way. Over the following weeks, those who respond often describe a gradual sense of improved recovery, less nagging discomfort, or better tolerance of training and daily activity.

The most useful approach is to track specific, measurable markers such as pain levels, range of motion, digestive symptoms, or training capacity, rather than chasing a day-by-day feeling. If nothing has changed after a reasonable, supervised trial, that's important information too.

In Your System

How long does BPC-157 stay in your system?

BPC-157 does not stay in your system long, because it leaves the bloodstream quickly. In rats and dogs its elimination half-life was under 30 minutes (He et al., 2022), and the 2025 HSS Journal review reports it is metabolized in the liver and cleared by the kidneys (Vasireddi et al., 2025). Within a few hours of a dose, very little of the original peptide remains in circulation.

A short half-life does not mean any effect is equally short. Proposed effects on blood-vessel growth and repair signaling would play out in tissue over days to weeks, which is why reported timelines are measured in weeks even though the peptide itself is gone within hours. BPC-157 is also on the World Anti-Doping Agency's prohibited list, and athletes subject to testing should treat detection windows as a separate question for their sport's rules. In short, the peptide itself clears within hours, while any proposed effect plays out over weeks.

Course Length

How long should you take BPC-157?

There is no established, evidence-based course length for BPC-157 in humans. Because no controlled trials have defined one, how long to take BPC-157 is set case by case by the prescribing clinician, based on the goal, the response and any side effects.

Without trial data, a defined course with a scheduled reassessment is more defensible than open-ended use. A course for gut-related goals and a course for a tendon problem may be framed differently. This is educational information, not a dosing instruction; do not start, extend or repeat a course without a physician.

Is It Permanent?

How long does BPC-157 last?

How long BPC-157's results last is unknown, because no human study has followed people after a BPC-157 course. BPC-157 is generally used in defined courses rather than indefinitely. When a tissue heals or a gut problem settles, that healing persists regardless of what helped it, which is why addressing the root cause matters more than the peptide.

For ongoing or structural problems, benefits may be more limited or temporary, which is exactly why BPC-157 belongs inside a larger plan rather than as a standalone fix.

Safety and Status

BPC-157 side effects and regulatory status

BPC-157 side effects in humans are poorly characterized. Animal safety studies reported no adverse effects across several organ systems, but the 2025 systematic review found no clinical safety data. The reviewers warned that adverse effects are possible because of unregulated manufacturing, contamination and unknown clinical safety. The FDA has said compounded BPC-157 may carry a risk of immune reactions and peptide-related impurities, and that it has little or no human safety information (FDA).

BPC-157 is not FDA-approved for any use, compounded drugs are not FDA-reviewed before marketing (FDA), and products sold online as research chemicals are not made to pharmaceutical standards; see pharmaceutical-grade vs research-grade peptides. If you are considering it, the safest route is a physician evaluation that weighs it against better-studied options.

The Protocol Approach

BPC-157 at Protocol Health

BPC-157 at Protocol Health starts with a peptide consultation covering your history, goals and, where relevant, lab work, and a physician decides whether BPC-157 is appropriate for you at all. When it is, it's used thoughtfully, monitored, and combined with the rehab, nutrition, and lifestyle inputs that actually drive recovery. BPC-157 is sometimes paired with TB-500; see the Wolverine stack.

We see patients in person at our Scarsdale clinic and by telehealth in New York, New Jersey, Connecticut, Florida and California. The bottom line on timing stays the same: users report gut changes within one to two weeks and tissue changes over several weeks, but no controlled human study has measured how long BPC-157 takes to work. See our peptide therapy page or take the quiz.

Bottom Line

The Bottom Line

BPC-157 timelines are expectations from user reports and animal biology, not trial data.

  • The mechanism is animal-derived. BPC-157 raised growth hormone receptor expression in tendon fibroblasts (Chang et al., 2014).
  • Repair biology is slow. Proposed angiogenic effects play out over weeks (Seiwerth et al., 2018).
  • Human data are thin. Musculoskeletal evidence is mostly animal studies (Tewari et al., 2026).
  • Compounded is not approved. The FDA does not review compounded drugs before marketing (FDA).
  • Use a defined course with reassessment. Open-ended use is harder to justify.

FAQ

Frequently Asked Questions

How soon will I feel results from BPC-157?

It varies, and no controlled human study has measured it. Gut-related goals are where people most often report noticing something, typically within one to two weeks, while tendon, ligament, and joint recovery usually unfold more gradually over several weeks. These are user reports, not trial results.

Does oral or injectable BPC-157 work faster?

No one knows: there are no comparative human data on oral versus injectable BPC-157. Oral forms are often discussed for gut-related goals because of the peptide's gastric origin, but that rationale comes from animal work, and the choice should be made with a clinician.

What if I don't notice anything after a few weeks?

That's meaningful feedback. It may mean BPC-157 isn't the right tool for your issue, that something else needs attention, or that expectations need adjusting. A supervised plan builds in check-ins so you're not guessing.

Can I speed up the results?

The biggest levers are usually the basics: consistent rehab, adequate protein and overall nutrition, quality sleep, and not overloading the tissue you're trying to heal. Peptides work best alongside those, not instead of them.

How long does BPC-157 stay in your system?

BPC-157 has a reported half-life of less than 30 minutes, is metabolized in the liver and is cleared by the kidneys, so very little remains in the blood within hours. Any effect on tissue is proposed to unfold over days to weeks, which is different from how long the peptide itself circulates.

Has BPC-157 been studied in humans?

Barely. A 2025 systematic review of BPC-157 in orthopaedic sports medicine found 35 animal studies and one small retrospective human study. Controlled human trials of how long BPC-157 takes to work, or whether it works, have not been published.

Is BPC-157 safe?

BPC-157 should only be used under medical supervision, after a provider has reviewed your health history and confirmed it's appropriate. Rigorous long-term human safety data is limited, which is another reason physician oversight matters.

Explore

Related at Protocol Health

See If Peptide Therapy Is Right for You

Medical disclaimer

This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.

Important safety information

References

  1. Vasireddi N et al., 2025. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. PMID 40756949. https://pubmed.ncbi.nlm.nih.gov/40756949/
  2. He L et al., 2022. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. PMID 36588717. https://pubmed.ncbi.nlm.nih.gov/36588717/
  3. Mendias CL et al., 2026. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. PMID 41966639. https://pubmed.ncbi.nlm.nih.gov/41966639/
  4. US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
  5. Chang CH et al., 2014. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. PMID 25415472. https://pubmed.ncbi.nlm.nih.gov/25415472/
  6. Seiwerth S et al., 2018. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Curr Pharm Des. PMID 29998800. https://pubmed.ncbi.nlm.nih.gov/29998800/
  7. US Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  8. Tewari K et al., 2026. Peptide Supplements and Their Therapeutic Applications in Sports Medicine. Am J Sports Med. PMID 42578445. https://pubmed.ncbi.nlm.nih.gov/42578445/

Why trust our physicians

Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.

Medically reviewed by
Richard Dentico, MD on
Written by
Protocol Health Editorial Team
First published
Last updated

See an error? Email care@protocolhealthmd.com and we will review it.

More on BPC-157 & TB-500

All Peptides articles →